Tuesday, February 17, 2026 at 11:09 AM
Danaher is nearing a $10 billion acquisition of Masimo, a pulse oximeter maker, which has a market cap of about $7 billion.
This deal would mark Danaher's first major acquisition since its purchase of Abcam in 2023.
Hims & Hers Health has agreed to acquire digital health company Eucalyptus in a deal valued at $1.15 billion in an effort to expand its geographic reach.
Negotiations over a deal for all shares in its competitor haven’t yet resulted in any binding agreement.
Gilead Sciences has agreed to buy the rest of development partner Arcellx in a deal that values the biotechnology company at about $7.8 billion at closing.
The Australian logistics operator has agreed to support a takeover offer from a consortium led by Macquarie Asset Management that values its equity at $6.51 billion.
